OPKO HEALTH, INC.

A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.

OPK | US

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 4400 BISCAYNE BLVD., 33137 MIAMI
Website:: https://www.opko.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on developing and commercializing innovative healthcare solutions. The company operates through two primary segments. Its pharmaceutical division develops novel therapies, with key products including NGENLA™, a long-acting human growth hormone treatment, and RAYALDEE®. The research pipeline focuses on multispecific therapies for cancer and infectious diseases, supported by partnerships with major pharmaceutical organizations. The diagnostics division, through its subsidiary BioReference Laboratories, is one of the largest full-service clinical reference laboratories in the U.S., offering a comprehensive portfolio of testing services to physicians and patients. By integrating its therapeutic and diagnostic capabilities, OPKO aims to establish leading positions in large, growing healthcare markets and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OPKO HEALTH, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO HEALTH, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for OPKO HEALTH, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
HLB Genex, Inc. Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.	South Korea	187420
HLB INC. A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.	South Korea	028300
HLB Life Science CO.,LTD. Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.	South Korea	067630
HLB PANAGENE Co., LTD. A global leader in PNA technology for cancer diagnostics and precision medicine.	South Korea	046210
HLB Pep Co., Ltd. Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.	South Korea	196300
HLB PHARMACEUTICAL CO., LTD. Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.	South Korea	047920
HLB SCIENCE Inc. Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.	South Korea	343090
H. Lundbeck A Develops and commercializes innovative therapeutics for brain diseases globally.	Denmark	HLUN
Hoth Therapeutics, Inc. Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.	United States of America	HOTH
Hugel, Inc. Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.	South Korea	145020